St. Jude kept at market perform by JMP

JMP Securities analyst Robert C. Faulkner maintained St. Jude Medical, Inc. at market perform as ICDs continue to decline into the third quarter, according to the analyst. JMP lowered its 2006 earnings per share estimate to $1.52, from $1.53, and 2007 earnings per share to $1.79, from $1.82. Shares of the St. Paul, Minn.-based medical device company were down $4.12, or 10.89%, at $33.70, on volume of 14,902,900 shares versus the three-month running average of 4,137,590 shares. (NYSE: STJ)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.